A Randomized, Multicenter Study Comparing Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Recipients With Chronic Hepatitis C†
Göran B. Klintmalm(Baylor University Medical Center), Carlos G. Fasola(Emory University), John P. Roberts(University of California, San Francisco), Stephen M. Rudich(University of Cincinnati), J. Michael Millis(University of Chicago), Linda W. Jennings(Baylor University Medical Center), David C. Mulligan(Yale University), Lewis Teperman(Hofstra University), Timothy L. Pruett(University of Minnesota), Milan Kinkhabwala(Albert Einstein College of Medicine), Hugo E. Vargas(Mayo Clinic in Arizona), Devin E. Eckhoff(University of Alabama at Birmingham), Elizabeth A. Pomfret(Tufts Medical Center), Michael Charlton(Madrigal Pharmaceuticals (United States)), Prabhakar K. Baliga(Medical University of South Carolina), George J. Netto(University of Pennsylvania), Gary L. Davis(Vrije Universiteit Amsterdam), Michaël Abécassis(University of Arizona), Kenneth Washburn(The Ohio State University Wexner Medical Center), Robert S. Brown(Cornell University), Thomas G. Heffron(Emory University), J. M. Ham(Oregon Health & Science University), David D. Douglas(WinnMed), Baburao Koneru(Rutgers, The State University of New Jersey), Linda Sher(University of Southern California)
Cited by 100
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k